Is Medico Intercontinental a good stock to invest in?

Medico Intercontinental can be analyzed on the following key metrics - TTM P/E: 7.02 Sector P/E: 0 Dividend Yield: 0% D/E ratio: -

Medico Intercontinental Share Price

Sector: Biotechnology & Drugs

Powered by

40.80 -0.11 (-0.27%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 38.50

Today’s High 42.79

52 Week Low 34.21

52 Week High 63.59

Key Metrics

Market Cap (In Cr) 40.96
Beta 1.04
Div. Yield (%) 0
P/B 0.82
TTM P/E 7.02
Sector P/E 0
D/E 0
Open Price 42.79
Prev Close 40.91

View All Metrics

Medico Intercontinental Analysis

Price Analysis

1 Week

-3.26%
3 Months

-0.84%
6 Month

-25.89%
YTD

-24.37%
1 Year

-8.36%

Risk Meter

49% Low risk
49% Moderate risk
49% Balanced Risk
49% High risk
49% Extreme risk

Medico Intercontinental Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
96.02

Selling/ General/ Admin Expenses Total
4.75

Depreciation/ Amortization
0.81

Other Operating Expenses Total
7.88

Total Operating Expense
88.05

Operating Income
7.97

Net Income Before Taxes
6.97

Net Income
5.06

Diluted Normalized EPS
5.06

Period
2024

Total Revenue
71.36

Selling/ General/ Admin Expenses Total
3.92

Depreciation/ Amortization
0.29

Other Operating Expenses Total
6.36

Total Operating Expense
65.42

Operating Income
5.93

Net Income Before Taxes
5.44

Net Income
3.95

Diluted Normalized EPS
3.95

Period
2023

Total Revenue
76.23

Selling/ General/ Admin Expenses Total
3.22

Depreciation/ Amortization
0.2

Other Operating Expenses Total
4.93

Total Operating Expense
70.66

Operating Income
5.56

Net Income Before Taxes
4.94

Net Income
3.61

Diluted Normalized EPS
5.61

Period
2022

Total Revenue
74.26

Selling/ General/ Admin Expenses Total
2.31

Depreciation/ Amortization
0.21

Other Operating Expenses Total
5.8

Total Operating Expense
69.16

Operating Income
5.1

Net Income Before Taxes
4.23

Net Income
3.1

Diluted Normalized EPS
9.54

Period
2021

Total Revenue
69.74

Selling/ General/ Admin Expenses Total
2.17

Depreciation/ Amortization
0.14

Other Operating Expenses Total
5

Total Operating Expense
64.93

Operating Income
4.81

Net Income Before Taxes
3.53

Net Income
2.58

Diluted Normalized EPS
7.93

Period
2020

Total Revenue
81.96

Selling/ General/ Admin Expenses Total
3.22

Depreciation/ Amortization
0.1

Other Operating Expenses Total
5

Total Operating Expense
77.67

Operating Income
4.3

Net Income Before Taxes
3.2

Net Income
2.36

Diluted Normalized EPS
7.25

Period
2019

Total Revenue
9.95

Selling/ General/ Admin Expenses Total
0.11

Depreciation/ Amortization
0

Other Operating Expenses Total
-0.07

Total Operating Expense
8.94

Operating Income
1.01

Net Income Before Taxes
1.01

Net Income
0.74

Diluted Normalized EPS
2.27

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Medico Intercontinental Technical

Moving Average SMA

5 Day41.17
10 Day40.72
20 Day40.01

50 Day38.91
100 Day41.16
300 Day46.08

Medico Intercontinental Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Chandra Bhagat Pharma
58.95
0.95
1.64
110.75
46.15
44.48

Gujarat Terce Laboratories
56.25
0.26
0.46
94.9
44.52
41.74

Medico Intercontinental
40.8
-0.11
-0.27
63.59
34.21
40.96

Ang Lifesciences India
30
-0.5
-1.64
62.75
21.03
39.18

Veerhealth Care
18
0.12
0.67
27
9.29
36

Medico Intercontinental Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

30-May-25
Audited Results

14-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results

13-Aug-24
Quarterly Results

25-May-24
Audited Results

10-May-24
Others

07-May-24
Others

14-Feb-24
Quarterly Results

08-Nov-23
Quarterly Results

14-Aug-23
Quarterly Results

Meeting Date
Announced on
Purpose

27-Sept-24
13-Aug-24
AGM

30-Jun-23
29-May-23
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

29-May-23
23-Jun-23
23-Jun-23
0.1

View All

Company Profile

ABOUT Medico Intercontinental

Industry Biotechnology & Drugs
ISIN INE858Q01019
BSE Code 539938

Medico Intercontinental Ltd is engaged in the business of trading pharmaceutical products. It provides a platform for all research-based biopharmaceutical companies. Its product categories include Gastro, Uro, Nutrition, Cosmetology, Health devices, Hospital, and other areas. Its products include ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, ALFACARE-D3, ARSUFACT Combokit, BALOFACT, CYCLOFACT 400, UDIFACT 150, XOFACT-4, ZIFT SL-250, ZYMIX, ARGIFACT, CLIANCIACT POWDER, RELIEVE CZ, VOLIREX SPRAY, RACIMAX SACHET, PERMACT, OROFACT, KTZ, FEMYACT, LIVOFACT, ZYMIX SY, ULTRATONE SY, ALBECTIN SUS, BECOFACT DROPS, MEFACT P SUS, ONCARE SOLUTION, OFCARE-FORTE SUS, PRODOM CV SY, RELIBEN SUSP, ZIFT SUSP-200, MGCIPACT EYE DROP, OROFACT-PASTE (lamy), OROFACT MOUTH ULCER GEL, CAMBOGIA, LUBRIACT, HIZEN, and CALAMED LOTION. Its subsidiaries include Evagrace Pharma Private Limited, Ritz Formulations Private Limited, Sungrace Pharma Private Limited, and Azillian Healthcare Private Limited.

MEDICO INTERCONTINENTAL SUMMARY

Medico Intercontinental is trading 0.27% lower at Rs 40.80 as compared to its last closing price. Medico Intercontinental has been trading in the price range of 42.79 & 38.50. Medico Intercontinental has given -24.37% in this year & -3.26% in the last 5 days.

Medico Intercontinental has TTM P/E ratio 7.02.

The company posted a net profit of 1.17 Crores in its last quarter.

Listed peers of Medico Intercontinental include Chandra Bhagat Pharma (1.64%), Gujarat Terce Laboratories (0.46%), Medico Intercontinental (-0.27%) etc.

Medico Intercontinental has a 55.17% promoter holding & 44.83% public holding.

FAQs about Medico Intercontinental

Medico Intercontinental is trading at 40.80 as on 12 Jun, 2025 3:13:33 PM. This is -0.27% lower as compared to its previous closing price of 40.91

The market capitalization of Medico Intercontinental is 40.96 Cr as on 12 Jun, 2025 3:13:33 PM.

The 52 wk high for Medico Intercontinental is 63.59 whereas the 52 wk low is 34.21

Medico Intercontinental can be analyzed on the following key metrics -

TTM P/E: 7.02
Sector P/E: 0
Dividend Yield: 0%
D/E ratio: -

Medico Intercontinental reported a net profit of 5.06 Cr in 2025.

Medico Intercontinental Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Medico Intercontinental Share Price

Price Range

Key Metrics

Medico Intercontinental Analysis

Medico Intercontinental Financials

Forecast

Forecast

Forecast

Medico Intercontinental Technical

Medico Intercontinental Peers

Medico Intercontinental Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Medico Intercontinental

MEDICO INTERCONTINENTAL SUMMARY

FAQs about Medico Intercontinental

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue